Sign in
4

Changes in Ownership

Armata Pharmaceuticals, Inc. Filed Acc 0001209191-17-065259

Chief Executive Officer acquired 599 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
GRINT PAUL C Chief Executive Officer 2017-12-08 Grant or award +599 $0.62 $371 599 D
Loading xslF345X03/doc4.xml…